Has Ricardo Silva, MD received payments from drug or device companies?

Yes. Drug and device makers reported $867,167 in general payments to Ricardo Silva, MD across 1,295 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ricardo Silva, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ricardo Silva, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ricardo Silva, MD

Endocrinology, Diabetes & Metabolism · Jacksonville, FLNPI 1619979788

Payments from drug & device makers

$867,167in general payments, 2019–2025

Across 1,295 payments — averaging $669.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eli Lilly$405K
Boehringer Ingelheim International GmbH$274K
Boehringer Ingelheim Pharma GmbH & Co.kg$152K
Sanofi-aventis U.S. LLC$7K
AbbVie$4K
Pfizer$3K
plus $21K from 40 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eli Lilly	7	$405,254
Boehringer Ingelheim International GmbH	46	$273,673
Boehringer Ingelheim Pharma GmbH & Co.kg	11	$152,487
Sanofi-aventis U.S. LLC	91	$7,007
AbbVie	24	$4,369
Pfizer	10	$3,499
Abbott	180	$3,496
Novo Nordisk	225	$2,828
Insulet Corporation	65	$1,600
Mannkind Corporation	58	$1,318
Lilly USA, LLC	60	$1,182
Amgen(2 entities)	55	$1,150
Corcept Therapeutics	52	$1,130
Bayer	49	$978
Boehringer Ingelheim	44	$946
AstraZeneca(2 entities)	43	$817
Xeris Pharmaceuticals, Inc.	43	$817
Medtronic(2 entities)	44	$760
Radius Health, Inc.	30	$595
Dexcom, Inc.	23	$470
Tandem Diabetes Care, Inc.	18	$326
IBSA Pharma Inc.	17	$265
Ascendis Pharma Endocrinology Inc	8	$240
Cequr Corporation	1	$227
Sequel Med Tech, LLC	4	$210
Valeritas, Inc.	11	$202
Amneal Pharmaceuticals LLC	11	$174
Merck	11	$158
Endo Pharmaceuticals Inc.	9	$119
Novartis	5	$109
Zealand Pharma US, Inc.	5	$106
Johnson & Johnson	7	$86
Neurocrine Biosciences, Inc.	3	$78
Shire North American Group Inc	5	$68
Boston Scientific	2	$62
Rhythm Pharmaceuticals, Inc.	2	$57
Astellas Pharma US Inc	3	$52
Lifescan, Inc.	3	$45
Globus Medical	2	$36
Senseonics, Incorporated	2	$35
Chiesi USA, Inc.	1	$35
Philips North America LLC	1	$30
Ultragenyx Pharmaceutical Inc.	1	$24
Acella Pharmaceuticals, LLC	1	$16
Recordati_rare_diseases_inc.	1	$16
Almatica Pharma LLC	1	$16

How this compares

$867,167 in reported general payments places this provider in the 95th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Medicare billing

Part B allowed, 2024

$186,298

Medicare patients

575

Services billed

2,279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Jacksonville

David SuttonJacksonville$3.1M
Mae Sheikh AliJacksonville$2.9M
James MageeJacksonville$2.7M
Senan SultanJacksonville$2.5M
J EvansJacksonville$1.7M
Wasim DeebJacksonville$1.5M
Anil ShresthaJacksonville$602K
Joe ChehadeJacksonville$542K
Firas WardaJacksonville$440K
Khurram WadudJacksonville$338K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →